This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Orion Infusions's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was BDT40.471. Orion Infusions's 10-Year median PS Ratio is 1.8455. Therefore, the Median PS Value for today is BDT74.69.
As of today (2024-05-14), Orion Infusions's share price is BDT596.50. Orion Infusions's Median PS Value is BDT74.69. Therefore, Orion Infusions's Price to Median PS Value for today is 7.99.
The historical rank and industry rank for Orion Infusions's Median PS Value or its related term are showing as below:
DHA:ORIONINFU'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 3.64 Med: 4.53 Max: 8.37
Current: 7.99
During the past 13 years, the highest Price to Median PS Value of Orion Infusions was 8.37. The lowest was 3.64. And the median was 4.53.
DHA:ORIONINFU's Price-to-Median-PS-Value is ranked worse than 98.81% of 504
companies
in the Drug Manufacturers industry
Industry Median: 0.87
vs DHA:ORIONINFU: 7.99
Orion Infusions Median PS Value Historical Data
The historical data trend for Orion Infusions's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Orion Infusions's Median PS Value
For the Drug Manufacturers - Specialty & Generic subindustry, Orion Infusions's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orion Infusions's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Orion Infusions's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Orion Infusions's Price-to-Median-PS-Value falls into.
Orion Infusions Median PS Value Calculation
Orion Infusions's Median PS Value for today is calculated as
10-Year Median PS Ratio is 1.8455.
Orion Infusions's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT40.471.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orion Infusions (DHA:ORIONINFU) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Orion Infusions's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
596.50
/
74.69
=
7.99
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orion Infusions Median PS Value Related Terms
Thank you for viewing the detailed overview of Orion Infusions's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Orion Infusions (DHA:ORIONINFU) Business Description
Orion Infusions Ltd is a pharmaceutical company. It produces various types of intravenous fluids, rehydration solutions, electrolyte solutions, antimicrobial products, and other pharmaceutical products in Bangladesh. The products of the company include Dextrolac, Dextropac, Dextrosal, Dianak, Electro dex, fructose, Hartman, Intralipid, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. In addition, the company is also involved in activities related to cosmetics and toiletries, infrastructure development, real estate and construction, power, agro products, hospitality, textiles and garments, and aviation management sectors. Geographically, it operates in Bangladesh.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DHA:ORIONINFU has been successfully added to your 